Literature DB >> 7427626

Dapsone-induced optic atrophy and motor neuropathy.

M Homeida, A Babikr, T K Daneshmend.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7427626      PMCID: PMC1714486          DOI: 10.1136/bmj.281.6249.1180

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  3 in total

1.  Fatal poisoning with udolac (diaminodiphenylsulphone).

Authors:  R DAVIES
Journal:  Lancet       Date:  1950-05-13       Impact factor: 79.321

2.  High dose dapsone toxicity.

Authors:  W B Shelley; M I Goldwein
Journal:  Br J Dermatol       Date:  1976-07       Impact factor: 9.302

3.  Dapsone motor neuropathy--an axonal disease.

Authors:  L Gutmann; J D Martin; W Welton
Journal:  Neurology       Date:  1976-06       Impact factor: 9.910

  3 in total
  4 in total

1.  Prolonged pancytopenia in a gene therapy patient with ADA-deficient SCID and trisomy 8 mosaicism: a case report.

Authors:  Barbara C Engel; Greg M Podsakoff; Joanna L Ireland; E Monika Smogorzewska; Denise A Carbonaro; Kathy Wilson; Ami Shah; Neena Kapoor; Mirna Sweeney; Mark Borchert; Gay M Crooks; Kenneth I Weinberg; Robertson Parkman; Howard M Rosenblatt; Shi-Qi Wu; Michael S Hershfield; Fabio Candotti; Donald B Kohn
Journal:  Blood       Date:  2006-09-14       Impact factor: 22.113

Review 2.  Dapsone in dermatology and beyond.

Authors:  Gottfried Wozel; Christian Blasum
Journal:  Arch Dermatol Res       Date:  2013-12-06       Impact factor: 3.017

Review 3.  A comprehensive insight into the anti-inflammatory properties of dapsone.

Authors:  Mina Khalilzadeh; Maryam Shayan; Sina Jourian; Mohammad Rahimi; Mohammad Sheibani; Ahmad Reza Dehpour
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2022-09-20       Impact factor: 3.195

4.  Bilateral exudative retinal detachments and associated choroidal detachments in a patient on dapsone: a case report.

Authors:  Sarah P Dugan; Hakan Demirci
Journal:  Int J Retina Vitreous       Date:  2022-05-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.